Novadaq Technologies Inc. (NVDQ) Analysts See $-0.21 EPS, Synalloy Has 2.29 Sentiment

July 3, 2017 - By Clifton Ray

Synalloy Corporation is a chemical manufacturing company. The company has market cap of $99.91 million. The Firm operates through two divisions: the Metals Segment and the Specialty Chemicals Segment. It currently has negative earnings. The Company’s Metals Segment comprises three subsidiaries: Synalloy Metals, Inc., which owns Bristol Metals, LLC , located in Bristol, Tennessee; Palmer of Texas Tanks, Inc. (Palmer), located in Andrews, Texas; and Specialty Pipe & Tube, Inc. (Specialty), located in Mineral Ridge, Ohio and Houston, Texas.

Analysts expect Novadaq Technologies Inc. (NASDAQ:NVDQ) to report $-0.21 EPS on July, 26.They anticipate $0.08 EPS change or 27.59% from last quarter’s $-0.29 EPS. After having $-0.24 EPS previously, Novadaq Technologies Inc.’s analysts see -12.50% EPS growth. It closed at $11.72 lastly. It is down 24.90% since July 3, 2016 and is downtrending. It has underperformed by 41.60% the S&P500.

Among 7 analysts covering Novadaq Technologies Inc (NASDAQ:NVDQ), 5 have Buy rating, 0 Sell and 2 Hold. Therefore 71% are positive. Novadaq Technologies Inc had 10 analyst reports since October 7, 2015 according to SRatingsIntel. The rating was initiated by Wedbush with “Outperform” on Wednesday, October 7. First Analysis upgraded Novadaq Technologies Inc. (NASDAQ:NVDQ) on Thursday, October 29 to “Overweight” rating. The stock has “Hold” rating by Craig Hallum on Monday, June 19. RBC Capital Markets maintained Novadaq Technologies Inc. (NASDAQ:NVDQ) rating on Wednesday, January 11. RBC Capital Markets has “Outperform” rating and $13 target. The stock of Novadaq Technologies Inc. (NASDAQ:NVDQ) has “Mkt Outperform” rating given on Wednesday, January 6 by JMP Securities. The firm has “Outperform” rating given on Wednesday, January 11 by Wedbush. The rating was downgraded by William Blair on Wednesday, January 11 to “Market Perform”.

NOVADAQ Technologies Inc. is a medical device company. The company has market cap of $677.49 million. The Firm primarily develops, makes and markets real-time fluorescence imaging products that are designed for use by surgeons in the operating room and other clinical settings where open and minimally invasive surgery or interventional procedures are performed. It currently has negative earnings. The Company’s SPY fluorescence imaging technology platform provides clinically relevant anatomic and physiologic images of blood flow in vessels and micro-vessels during a range of surgical and outpatient procedures performed in the operating room or clinic.

The stock increased 1.78% or $0.2 on June 30, reaching $11.35. About shares traded. Synalloy Corporation (SYNL) has risen 59.68% since July 3, 2016 and is uptrending. It has outperformed by 42.98% the S&P500.